US Stock MarketDetailed Quotes
IZTC Invizyne Technologies
- 14.400
- +0.560+4.05%
Trading Nov 27 09:40 ET
137.21MMarket Cap-26765P/E (TTM)
14.400High14.100Low1.03KVolume14.100Open13.840Pre Close14.66KTurnover0.06%Turnover RatioLossP/E (Static)9.53MShares19.37052wk High-38.10P/B27.00MFloat Cap8.50052wk Low--Dividend TTM1.88MShs Float19.370Historical High--Div YieldTTM2.17%Amplitude8.500Historical Low14.250Avg Price1Lot Size
About Invizyne Technologies Company
Invizyne Technologies, Inc. is a development stage synthetic biochemical company. Its synthetic biology platform would enable the scalable exploration of many molecules and properties found in nature. The company was founded by Tyler Korman and Paul Opgenorth in April 2019 and is headquartered in Monrovia, NV.
Company Profile
SymbolIZTC
Company NameInvizyne Technologies
Listing DateNov 13, 2024
Issue Price8.00
Founded2019
CEOMr. Michael Heltzen
MarketNASDAQ
Employees29
Fiscal Year Ends12-31
Address750 Royal Oaks Drive,Suite 106
CityMonrovia
ProvinceNevada
CountryUnited States of America
Zip Code91016
Phone1-626-415-1488
Websitehttp://www.invizyne.com
Company Executives
- Name
- Position
- Salary
- Michael Heltzen
- Chief Executive Officer
- --
- Fouad Nawaz
- Vice President, Finance and Principal Accounting Officer
- --
- Dr. Tyler Korman
- Vice President, Research
- 260.47K
- Dr. Paul Opgenorth
- Vice President, Development
- 251.69K
- Michael Burns
- Executive Vice President, Energy Transition
- --
- Dr. Zachary Karl, PhD
- Vice President and Head of Business Development
- --
- Mohammad Hayat
- Chairman of the Board and President
- 277.40K
- Christopher A. Marlett
- Director
- --
- Anthony Digiandomenico
- Director
- --
- Dr. Lon E. Bell,PhD
- Independent Director
- --
- Dr. James U. Bowie
- Independent Director
- --
- James Lalonde
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
